Format
Sort by
Items per page

Send to

Choose Destination

Best matches for María L. García:

Memantine for the Treatment of Dementia: A Review on its Current and Future Applications. Folch J et al. J Alzheimers Dis. (2018)

Memantine-Loaded PEGylated Biodegradable Nanoparticles for the Treatment of Glaucoma. Sánchez-López E et al. Small. (2018)

ICTV Virus Taxonomy Profile: Ophioviridae. García ML et al. J Gen Virol. (2017)

Search results

Items: 1 to 20 of 100

1.

Therapeutic Interventions for Countering Leishmaniasis and Chagas's Disease: From Traditional Sources to Nanotechnological Systems.

Souto EB, Dias-Ferreira J, Craveiro SA, Severino P, Sanchez-Lopez E, Garcia ML, Silva AM, Souto SB, Mahant S.

Pathogens. 2019 Aug 1;8(3). pii: E119. doi: 10.3390/pathogens8030119. Review.

2.

In Vitro Cytotoxicity of Oleanolic/Ursolic Acids-Loaded in PLGA Nanoparticles in Different Cell Lines.

Silva AM, Alvarado HL, Abrego G, Martins-Gomes C, Garduño-Ramirez ML, García ML, Calpena AC, Souto EB.

Pharmaceutics. 2019 Jul 24;11(8). pii: E362. doi: 10.3390/pharmaceutics11080362.

3.

Development of Pranoprofen Loaded Nanostructured Lipid Carriers to Improve Its Release and Therapeutic Efficacy in Skin Inflammatory Disorders.

Rincón M, Calpena AC, Fabrega MJ, Garduño-Ramírez ML, Espina M, Rodríguez-Lagunas MJ, García ML, Abrego G.

Nanomaterials (Basel). 2018 Dec 7;8(12). pii: E1022. doi: 10.3390/nano8121022.

4.

Skin-controlled release lipid nanosystems of pranoprofen for the treatment of local inflammation and pain.

Rincón M, Calpena AC, Clares B, Espina M, Garduño-Ramírez ML, Rodríguez-Lagunas MJ, García ML, Abrego G.

Nanomedicine (Lond). 2018 Oct;13(19):2397-2413. doi: 10.2217/nnm-2018-0195. Epub 2018 Oct 12.

PMID:
30311846
5.

Neoplastic Multifocal Skin Lesions: Biology, Etiology, and Targeted Therapies for Nonmelanoma Skin Cancers.

Fernandes AR, Santos AC, Sanchez-Lopez E, Kovačević AB, Espina M, Calpena AC, Veiga FJ, Garcia ML, Souto EB.

Skin Pharmacol Physiol. 2018;31(2):59-73. doi: 10.1159/000479529. Epub 2017 Dec 21. Review.

6.

Discovery of a potent and selective ROMK inhibitor with improved pharmacokinetic properties based on an octahydropyrazino[2,1-c][1,4]oxazine scaffold.

Zhu Y, de Jesus RK, Tang H, Walsh SP, Jiang J, Gu X, Teumelsan N, Shahripour A, Pio B, Ding FX, Ha S, Priest BT, Swensen AM, Alonso-Galicia M, Felix JP, Brochu RM, Bailey T, Thomas-Fowlkes B, Zhou X, Pai LY, Hampton C, Hernandez M, Owens K, Ehrhart J, Roy S, Kaczorowski GJ, Yang L, Parmee ER, Sullivan K, Garcia ML, Pasternak A.

Bioorg Med Chem Lett. 2016 Dec 1;26(23):5695-5702. doi: 10.1016/j.bmcl.2016.10.064. Epub 2016 Oct 24.

PMID:
27839686
7.

Preclinical safety of solid lipid nanoparticles and nanostructured lipid carriers: Current evidence from in vitro and in vivo evaluation.

Doktorovová S, Kovačević AB, Garcia ML, Souto EB.

Eur J Pharm Biopharm. 2016 Nov;108:235-252. doi: 10.1016/j.ejpb.2016.08.001. Epub 2016 Aug 9.

PMID:
27519829
8.

In vitro, ex vivo and in vivo characterization of PLGA nanoparticles loading pranoprofen for ocular administration.

Cañadas C, Alvarado H, Calpena AC, Silva AM, Souto EB, García ML, Abrego G.

Int J Pharm. 2016 Sep 25;511(2):719-27. doi: 10.1016/j.ijpharm.2016.07.055. Epub 2016 Jul 30.

PMID:
27480398
9.

Discovery of MK-7145, an Oral Small Molecule ROMK Inhibitor for the Treatment of Hypertension and Heart Failure.

Tang H, Zhu Y, Teumelsan N, Walsh SP, Shahripour A, Priest BT, Swensen AM, Felix JP, Brochu RM, Bailey T, Thomas-Fowlkes B, Pai LY, Hampton C, Corona A, Hernandez M, Metzger J, Forrest M, Zhou X, Owens K, Tong V, Parmee E, Roy S, Kaczorowski GJ, Yang L, Alonso-Galicia M, Garcia ML, Pasternak A.

ACS Med Chem Lett. 2016 May 12;7(7):697-701. doi: 10.1021/acsmedchemlett.6b00122. eCollection 2016 Jul 14.

10.

The Renal Outer Medullary Potassium Channel Inhibitor, MK-7145, Lowers Blood Pressure, and Manifests Features of Bartter's Syndrome Type II Phenotype.

Hampton C, Zhou X, Priest BT, Pai LY, Felix JP, Thomas-Fowlkes B, Liu J, Kohler M, Xiao J, Corona A, Price O, Gill C, Shah K, Rasa C, Tong V, Owens K, Ormes J, Tang H, Roy S, Sullivan KA, Metzger JM, Alonso-Galicia M, Kaczorowski GJ, Pasternak A, Garcia ML.

J Pharmacol Exp Ther. 2016 Oct;359(1):194-206. doi: 10.1124/jpet.116.235150. Epub 2016 Jul 18.

PMID:
27432892
11.

Animal Assisted Therapy (AAT) Program As a Useful Adjunct to Conventional Psychosocial Rehabilitation for Patients with Schizophrenia: Results of a Small-scale Randomized Controlled Trial.

Calvo P, Fortuny JR, Guzmán S, Macías C, Bowen J, García ML, Orejas O, Molins F, Tvarijonaviciute A, Cerón JJ, Bulbena A, Fatjó J.

Front Psychol. 2016 May 6;7:631. doi: 10.3389/fpsyg.2016.00631. eCollection 2016.

12.

Ion channels find a pathway for therapeutic success.

Garcia ML, Kaczorowski GJ.

Proc Natl Acad Sci U S A. 2016 May 17;113(20):5472-4. doi: 10.1073/pnas.1605669113. Epub 2016 May 4. No abstract available.

13.

Differentiation of ROMK potency from hERG potency in the phenacetyl piperazine series through heterocycle incorporation.

Walsh SP, Shahripour A, Tang H, de Jesus RK, Teumelsan N, Zhu Y, Frie J, Priest BT, Swensen AM, Alonso-Galicia M, Felix JP, Brochu RM, Bailey T, Thomas-Fowlkes B, Zhou X, Pai LY, Hampton C, Hernandez M, Owens K, Ehrhart J, Roy S, Kaczorowski GJ, Yang L, Garcia ML, Pasternak A.

Bioorg Med Chem Lett. 2016 May 1;26(9):2339-43. doi: 10.1016/j.bmcl.2016.03.035. Epub 2016 Mar 12.

PMID:
27017115
14.

Biopharmaceutical evaluation of epigallocatechin gallate-loaded cationic lipid nanoparticles (EGCG-LNs): In vivo, in vitro and ex vivo studies.

Fangueiro JF, Calpena AC, Clares B, Andreani T, Egea MA, Veiga FJ, Garcia ML, Silva AM, Souto EB.

Int J Pharm. 2016 Apr 11;502(1-2):161-9. doi: 10.1016/j.ijpharm.2016.02.039. Epub 2016 Feb 24.

PMID:
26921515
15.

Ex vivo permeation of carprofen from nanoparticles: A comprehensive study through human, porcine and bovine skin as anti-inflammatory agent.

Parra A, Clares B, Rosselló A, Garduño-Ramírez ML, Abrego G, García ML, Calpena AC.

Int J Pharm. 2016 Mar 30;501(1-2):10-7. doi: 10.1016/j.ijpharm.2016.01.056. Epub 2016 Jan 27.

PMID:
26826569
16.

Lacrimal Cytokines Assessment in Subjects Exposed to Different Levels of Ambient Air Pollution in a Large Metropolitan Area.

Matsuda M, Bonatti R, Marquezini MV, Garcia ML, Santos UP, Braga AL, Alves MR, Saldiva PH, Monteiro ML.

PLoS One. 2015 Nov 20;10(11):e0143131. doi: 10.1371/journal.pone.0143131. eCollection 2015.

17.

Design and elaboration of freeze-dried PLGA nanoparticles for the transcorneal permeation of carprofen: Ocular anti-inflammatory applications.

Parra A, Mallandrich M, Clares B, Egea MA, Espina M, García ML, Calpena AC.

Colloids Surf B Biointerfaces. 2015 Dec 1;136:935-43. doi: 10.1016/j.colsurfb.2015.10.026. Epub 2015 Oct 26.

PMID:
26551871
18.

Discovery of a Potent and Selective ROMK Inhibitor with Pharmacokinetic Properties Suitable for Preclinical Evaluation.

Walsh SP, Shahripour A, Tang H, Teumelsan N, Frie J, Zhu Y, Priest BT, Swensen AM, Liu J, Margulis M, Visconti R, Weinglass A, Felix JP, Brochu RM, Bailey T, Thomas-Fowlkes B, Alonso-Galicia M, Zhou X, Pai LY, Corona A, Hampton C, Hernandez M, Bentley R, Chen J, Shah K, Metzger J, Forrest M, Owens K, Tong V, Ha S, Roy S, Kaczorowski GJ, Yang L, Parmee E, Garcia ML, Sullivan K, Pasternak A.

ACS Med Chem Lett. 2015 May 7;6(7):747-52. doi: 10.1021/ml500440u. eCollection 2015 Jul 9.

19.

Citrus psorosis virus 24K protein interacts with citrus miRNA precursors, affects their processing and subsequent miRNA accumulation and target expression.

Reyes CA, Ocolotobiche EE, Marmisollé FE, Robles Luna G, Borniego MB, Bazzini AA, Asurmendi S, García ML.

Mol Plant Pathol. 2016 Apr;17(3):317-29. doi: 10.1111/mpp.12282. Epub 2015 Jul 14.

20.

Effect of mucoadhesive polymers on the in vitro performance of insulin-loaded silica nanoparticles: Interactions with mucin and biomembrane models.

Andreani T, Miziara L, Lorenzón EN, de Souza AL, Kiill CP, Fangueiro JF, Garcia ML, Gremião PD, Silva AM, Souto EB.

Eur J Pharm Biopharm. 2015 Jun;93:118-26. doi: 10.1016/j.ejpb.2015.03.027. Epub 2015 Apr 3.

PMID:
25843239

Supplemental Content

Loading ...
Support Center